Sunzen Biotech Bhd (0148) — Financial Flexibility Index
Sunzen Biotech Bhd (0148) has a Financial Flexibility Index of 0.22x as of September 2023. Free cash flow of RM3.67 Million (operating CF RM3.58 Million minus capex RM95.00K) represents 0% of total liabilities (RM16.55 Million). Check 0148 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sunzen Biotech Bhd Financial Flexibility Index (2016–2023)
Historical Financial Flexibility Index trend for Sunzen Biotech Bhd across 8 annual periods. For the full cash flow conversion analysis, see Sunzen Biotech Bhd cash conversion from operations.
Annual Financial Flexibility Index for Sunzen Biotech Bhd (2016–2023)
Year-by-year free cash flow to debt coverage for Sunzen Biotech Bhd. Explore 0148 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (MYR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.09x | RM1.83 Million | RM819.39K | RM20.51 Million | ▲ +108.8% |
| 2022 | -1.02x | RM-29.59 Million | RM-32.06 Million | RM29.08 Million | ▼ -123.2% |
| 2021 | -0.46x | RM-13.96 Million | RM-16.36 Million | RM30.61 Million | ▼ -294.8% |
| 2020 | 0.23x | RM8.36 Million | RM7.20 Million | RM35.73 Million | ▲ +223.2% |
| 2019 | -0.19x | RM-7.02 Million | RM-11.05 Million | RM36.96 Million | ▼ -262.3% |
| 2018 | -0.05x | RM-2.13 Million | RM-4.07 Million | RM40.63 Million | ▼ -113.9% |
| 2017 | 0.38x | RM7.44 Million | RM4.02 Million | RM19.70 Million | ▼ -50.8% |
| 2016 | 0.77x | RM6.89 Million | RM256.13K | RM8.98 Million | — |